Eli Lilly and Company

Lilly Reports Strong First-Quarter 2009 Results

Published in FDA Law Weekly, May 7th, 2009

Q1 Revenue Increases 5% on a Reported Basis, Driven by Higher Volume. -- Foreign Exchange Rates Lead to Improved Gross Margin Percentage. -- Company Achieves Operating Leverage by Growing Revenue Faster Than

Cost of Sales and Operating Expenses. -- Earnings Rise 24% (reported) or 36% (pro forma non-GAAP) to $1.20 per

share. Eli Lilly and Company (NYSE:LLY) announced financial results for the first quarter of 2009. Due to significant strategic actions taken by the company in 2008, financial results for 2008 are presented on both a reported basis and a pro forma non-GAAP basis. Reported results were prepared in accordance with generally accepted...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of FDA Law Weekly

Source: FDA Law Weekly (2009-05-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry